203 related articles for article (PubMed ID: 15519122)
1. Hypersomnia and low cerebrospinal fluid hypocretin levels in acute disseminated encephalomyelitis.
Yoshikawa S; Suzuki S; Kanbayashi T; Nishino S; Tamai H
Pediatr Neurol; 2004 Nov; 31(5):367-70. PubMed ID: 15519122
[TBL] [Abstract][Full Text] [Related]
2. Normal levels of cerebrospinal fluid hypocretin-1 and daytime sleepiness during attacks of relapsing-remitting multiple sclerosis and monosymptomatic optic neuritis.
Knudsen S; Jennum PJ; Korsholm K; Sheikh SP; Gammeltoft S; Frederiksen JL
Mult Scler; 2008 Jul; 14(6):734-8. PubMed ID: 18505777
[TBL] [Abstract][Full Text] [Related]
3. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
Nishino S; Kanbayashi T
Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
[TBL] [Abstract][Full Text] [Related]
4. A patient with anti-aquaporin 4 antibody who presented with recurrent hypersomnia, reduced orexin (hypocretin) level, and symmetrical hypothalamic lesions.
Nozaki H; Shimohata T; Kanbayashi T; Sagawa Y; Katada S; Satoh M; Onodera O; Tanaka K; Nishizawa M
Sleep Med; 2009 Feb; 10(2):253-5. PubMed ID: 18226957
[TBL] [Abstract][Full Text] [Related]
5. Hypersomnolence and increased REM sleep with low cerebrospinal fluid hypocretin level in a patient after removal of craniopharyngioma.
Tachibana N; Taniike M; Okinaga T; Ripley B; Mignot E; Nishino S
Sleep Med; 2005 Nov; 6(6):567-9. PubMed ID: 16084764
[TBL] [Abstract][Full Text] [Related]
6. A case of acute disseminated encephalomyelitis presenting hypersomnia with decreased hypocretin level in cerebrospinal fluid.
Kubota H; Kanbayashi T; Tanabe Y; Takanashi J; Kohno Y
J Child Neurol; 2002 Jul; 17(7):537-9. PubMed ID: 12269735
[TBL] [Abstract][Full Text] [Related]
7. Excessive daytime sleepiness in Behçet's disease with diencephalic lesions and hypocretin dysfunction.
Baumann CR; Bassetti CL; Hersberger M; Jung HH
Eur Neurol; 2010; 63(3):190. PubMed ID: 20203518
[No Abstract] [Full Text] [Related]
8. Cerebrospinal hypocretin, daytime sleepiness and sleep architecture in Parkinson's disease dementia.
Compta Y; Santamaria J; Ratti L; Tolosa E; Iranzo A; Muñoz E; Valldeoriola F; Casamitjana R; Ríos J; Marti MJ
Brain; 2009 Dec; 132(Pt 12):3308-17. PubMed ID: 19858078
[TBL] [Abstract][Full Text] [Related]
9. Melanin concentrating hormone in central hypersomnia.
Peyron C; Valentin F; Bayard S; Hanriot L; Bedetti C; Rousset B; Luppi PH; Dauvilliers Y
Sleep Med; 2011 Sep; 12(8):768-72. PubMed ID: 21697009
[TBL] [Abstract][Full Text] [Related]
10. Narcolepsy caused by acute disseminated encephalomyelitis.
Gledhill RF; Bartel PR; Yoshida Y; Nishino S; Scammell TE
Arch Neurol; 2004 May; 61(5):758-60. PubMed ID: 15148155
[TBL] [Abstract][Full Text] [Related]
11. Normal cerebrospinal fluid levels of hypocretin-1 (orexin A) in patients with fibromyalgia syndrome.
Taiwo OB; Russell IJ; Mignot E; Lin L; Michalek JE; Haynes W; Xiao Y; Zeitzer JM; Larson AA
Sleep Med; 2007 Apr; 8(3):260-5. PubMed ID: 17369087
[TBL] [Abstract][Full Text] [Related]
12. Normal CSF hypocretin-1 (orexin A) levels in dementia with Lewy bodies associated with excessive daytime sleepiness.
Baumann CR; Dauvilliers Y; Mignot E; Bassetti CL
Eur Neurol; 2004; 52(2):73-6. PubMed ID: 15256827
[TBL] [Abstract][Full Text] [Related]
13. [Excessive daytime sleepiness and low CSF orexin-A/hypocretin-I levels in a patient with probable progressive supranuclear palsy].
Hattori Y; Hattori T; Mukai E; Mori H; Mizuno Y; Kayukawa Y; Okada T; Kanbayashi T
No To Shinkei; 2003 Dec; 55(12):1053-6. PubMed ID: 14870576
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid hypocretin-1 levels in multiple system atrophy.
Martinez-Rodriguez JE; Seppi K; Cardozo A; Iranzo A; Stampfer-Kountchev M; Wenning G; Tolosa E; Högl B; Santamaria J; Poewe W;
Mov Disord; 2007 Sep; 22(12):1822-4. PubMed ID: 17659646
[TBL] [Abstract][Full Text] [Related]
15. Hypersomnia and low CSF hypocretin-1 (orexin-A) concentration in a patient with multiple sclerosis showing bilateral hypothalamic lesions.
Kato T; Kanbayashi T; Yamamoto K; Nakano T; Shimizu T; Hashimoto T; Ikeda S
Intern Med; 2003 Aug; 42(8):743-5. PubMed ID: 12924505
[TBL] [Abstract][Full Text] [Related]
16. Low CSF hypocretin-1/orexin-A associated with hypersomnia secondary to hypothalamic lesion in a case of multiple sclerosis.
Oka Y; Kanbayashi T; Mezaki T; Iseki K; Matsubayashi J; Murakami G; Matsui M; Shimizu T; Shibasaki H
J Neurol; 2004 Jul; 251(7):885-6. PubMed ID: 15258796
[No Abstract] [Full Text] [Related]
17. CSF hypocretin-1 levels are normal in patients with amyotrophic lateral sclerosis.
Van Rooij FG; Schelhaas HJ; Lammers GJ; Verbeek MM; Overeem S
Amyotroph Lateral Scler; 2009; 10(5-6):487-9. PubMed ID: 19922146
[TBL] [Abstract][Full Text] [Related]
18. Symptomatic narcolepsy in patients with neuromyelitis optica and multiple sclerosis: new neurochemical and immunological implications.
Kanbayashi T; Shimohata T; Nakashima I; Yaguchi H; Yabe I; Nishizawa M; Shimizu T; Nishino S
Arch Neurol; 2009 Dec; 66(12):1563-6. PubMed ID: 20008665
[TBL] [Abstract][Full Text] [Related]
19. Hypersomnia, REM sleep fragmentation and loss of motivation in a patient with hypothalamic lesions.
Poryazova R; Werth E; Bassetti CL; Khatami R
Sleep Med; 2009 Aug; 10(7):812-3. PubMed ID: 19185536
[No Abstract] [Full Text] [Related]
20. Acute disseminated encephalomyelitis: an MRI/MRS longitudinal study.
Gabis LV; Panasci DJ; Andriola MR; Huang W
Pediatr Neurol; 2004 May; 30(5):324-9. PubMed ID: 15165634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
